• Total investment of EUR 105 million in Prevalje site reinforces commitment to largest Sandoz business, Anti-Infectives, and single largest global product, broad-spectrum antibiotic amoxicillin-clavulanic acid.
• The investment will bring 150 new jobs, more than doubling the number of employees at Prevalje over six years.
• The project, scheduled for completion in 2019, will be the largest Novartis investment in Slovenia to date.

Prevalje, April 11, 2017 – A foundation stone for the new production plant for a broad- …